FONTEYNE PAUL R. 4
4 · Amylyx Pharmaceuticals, Inc. · Filed Jun 7, 2024
Insider Transaction Report
Form 4
FONTEYNE PAUL R.
Director
Transactions
- Award
Stock Option (right to buy)
2024-06-06+25,000→ 25,000 totalExercise: $1.76Exp: 2034-06-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.